Accueil > Actualité
Actualite financiere : Actualite bourse

Roche: signs technology licensing deal with Amunix

( - US biopharmaceutical firm Amunix said on Friday that it has signed a deal to provide a technology license that will help the Swiss drugmaker discover and develop non-oncology therapeutics.

The Mountain View, California-based company said it will receive a 40 million dollar upfront payment under the terms of the deal.

The firm may also receive up to 1.5 billion dollars in payments, depending on the achievement of certain developmental and sales milestones, plus royalties on sales of commercialized products.

Amunix uses precision protein engineering to enable T cell engagers and cytokines to treat patients with solid tumors.

Copyright (c) 2020 All rights reserved.




Qui sommes-nous ? | Nous contacter | FAQ | Mentions légales | RSS | © Copyright 2007 Cercle Finance. Tous droits réservés.
Indices et cours différés d’au moins 15 mn | Cotations boursières fournies par ABC Bourse.